Topics

J&J submits EMA applications for Ebola vaccine

06:52 EST 8 Nov 2019 | PharmaTimes

The MAAs are supported by data from Phase I, II and III clinical studies.

Original Article: J&J submits EMA applications for Ebola vaccine

NEXT ARTICLE

More From BioPortfolio on "J&J submits EMA applications for Ebola vaccine"

Quick Search

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...